Paper
Dupilumab is associated with improved lung functions in patients with COPD and type 2 inflammation: a post hoc analysis of the BOREAS and NOTUS trials
American Journal of Respiratory and Critical Care Medicine · 2026 · MeiLan K Han, Klaus F Rabe, Frank C Sciurba et al.